中大學術數位典藏-NCU Institutional Repository-提供博碩士論文、考古題、期刊論文、研究計畫等下載:Item 987654321/102584
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 94274/94274 (100%)
造访人次 : 82911178      在线人数 : 2247
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.lib.ncu.edu.tw/handle/987654321/102584


    题名: Liver-Specific Expressions of HBx and src in the p53 Mutant Trigger Hepatocarcinogenesis in Zebrafish
    作者: 金秀蓮;Lu, Jeng-Wei;Yang, Wan-Yu;Tsai, Su-Mei;Lin, Yueh-Min;Chang, Pen-Heng;Chen, Jim-Ray;Wang, Horng-Dar;Wu, Jen-Leih;Jin, Shiow-Lian Catherine;Yuh, Chiou-Hwa
    贡献者: 生醫理工學院生命科學系
    关键词: Activation;AKT protein;Animal genetic engineering;Animals;Animals, Genetically Modified;Apoptosis - genetics;Biomarkers, Tumor - metabolism;Cancer;Cancer screening;Carcinogenesis - genetics;Carcinoma, Hepatocellular - genetics;Carcinoma, Hepatocellular - metabolism;Carcinoma, Hepatocellular - pathology;Cell cycle;Cell Cycle - genetics;Danio rerio;Development and progression;Drug screening;Enzyme Activation - genetics;Etiology;Extracellular signal-regulated kinase;Fatty liver;Fibrosis;Gene Expression;Gene regulation;Genes;Genetic aspects;Glucose metabolism;Glycogen;Glycogen - metabolism;Health aspects;Hepatitis;Hepatitis B;Hepatitis B virus;Hepatocellular carcinoma;Humans;Hyperplasia;Hyperplasia - genetics;Kinases;Lipid metabolism;Lipogenesis - genetics;Liver;Liver - metabolism;Liver - pathology;Liver cancer;Liver Neoplasms - genetics;Liver Neoplasms - metabolism;Liver Neoplasms - pathology;Metabolism;Molecular chains;Mutants;Mutation;Myc protein;Neoplasm Metastasis;Organ Specificity;p53 Protein;Physiological aspects;Proliferating Cell Nuclear Antigen - metabolism;Protein-tyrosine kinase;Proteins;Recombinant Fusion Proteins - genetics;Rodents;Signal Transduction - genetics;src-Family Kinases - genetics;Steatosis;Synergistic effect;Synergistic effects;Trans-Activators - genetics;Transgenic;Tumor proteins;Tumor Suppressor Protein p53 - genetics;Tumorigenesis;Tyrosine;Vascular endothelial growth factor;Viruses;Zebrafish;Zebrafish - genetics;Zebrafish - metabolism
    日期: 2013-10-09
    上传时间: 2026-04-23 11:13:14 (UTC+8)
    出版者: Public Library of Science;United States: Public Library of Science (PLoS)
    摘要: 摘要: Hepatocarcinogenesis is a multistep process that starts from fatty liver and transitions to fibrosis and, finally, into cancer. Many etiological factors, including hepatitis B virus X antigen (HBx) and p53 mutations, have been implicated in hepatocarcinogenesis. However, potential synergistic effects between these two factors and the underlying mechanisms by which they promote hepatocarcinogenesis are still unclear. In this report, we show that the synergistic action of HBx and p53 mutation triggers progressive hepatocellular carcinoma (HCC) formation via src activation in zebrafish. Liver-specific expression of HBx in wild-type zebrafish caused steatosis, fibrosis and glycogen accumulation. However, the induction of tumorigenesis by HBx was only observed in p53 mutant fish and occurred in association with the up-regulation and activation of the src tyrosine kinase pathway. Furthermore, the overexpression of src in p53 mutant zebrafish also caused hyperplasia, HCC, and sarcomatoid HCC, which were accompanied by increased levels of the signaling proteins p-erk, p-akt, myc, jnk1 and vegf. Increased expression levels of lipogenic factors and the genes involved in lipid metabolism and glycogen storage were detected during the early stages of hepatocarcinogenesis in the HBx and src transgenic zebrafish. The up-regulation of genes involved in cell cycle regulation, tumor progression and other molecular hallmarks of human liver cancer were found at later stages in both HBx and src transgenic, p53 mutant zebrafish. Together, our study demonstrates that HBx and src overexpression induced hepatocarcinogenesis in p53 mutant zebrafish. This phenomenon mimics human HCC formation and provides potential in vivo platforms for drug screening for therapies for human liver cancer.
    其他題名: PLoS One
    出版者: United States: Public Library of Science (PLoS)
    出版日期: 2013-10-09
    出處: PLoS ONE, 2013-10, Vol.8 (10), p.e76951-
    資源來源: Agricultural & Environmental Science Collection
    版權: COPYRIGHT 2013 Public Library of Science
    版權: 2013 Lu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
    版權: 2013 Lu et al 2013 Lu et al
    識別號: ISSN: 1932-6203
    識別號: EISSN: 1932-6203
    識別號: DOI: 10.1371/journal.pone.0076951
    識別號: PMID: 24130815
    显示于类别:[生命科學系] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML20检视/开启


    在NCUIR中所有的数据项都受到原著作权保护.

    社群 sharing

    ::: Copyright National Central University. | 國立中央大學圖書館版權所有 | 收藏本站 | 設為首頁 | 最佳瀏覽畫面: 1024*768 | 建站日期:8-24-2009 :::
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 隱私權政策聲明